NLRP3 inflammasome: a new promising therapeutic target to treat heart failure. Giuseppe Del Buono M, Crea F, Versaci F, Biondi-Zoccai G, et al. J Cardiovasc Pharmacol 2020 Nov 2. doi: 10.1097/FJC.0000000000000946.

Read + Share

Amedeo Smart

Independent Medical Education

Giuseppe Del Buono M, Crea F, Versaci F, Biondi-Zoccai G, et al. NLRP3 inflammasome: a new promising therapeutic target to treat heart failure. J Cardiovasc Pharmacol 2020 Nov 2. doi: 10.1097/FJC.0000000000000946.
PMID: 33165145